Prova Health

What Prova Health does

Prova Health is a London-based health innovation consultancy founded in 2020 that delivers three integrated practice areas: Clinical Evidence (including a proprietary clinical simulation methodology for evaluating AI/LLM-based healthcare technologies, pragmatic trials, and real-world evidence generation), Economic Evidence (health economics and outcomes research, cost-effectiveness modelling), and Market Access (commercialisation support including DiGA reimbursement navigation in Germany and US healthcare market entry). The firm also operates the Prova Health Network, a platform connecting 100,000+ clinicians and healthcare professionals across 25+ therapeutic areas and 50+ countries for validation activities, and the "Learn by Prova Health" online learning platform for capability building programmes. Its primary customer segments are global pharmaceutical companies (including disclosed engagements with a top-5 and top-10 global life sciences/pharma firm), digital health and AI innovators (Roche navify Clinical Hub, getUBetter, Outbound AI), and health systems.

The company monetises exclusively through professional services — project-based, quote-driven consulting engagements rather than productised subscriptions or licensing. GTM is consultative enterprise field sales, primarily direct engagement with senior stakeholders in pharma, digital health, and health systems. Service delivery is led by clinicians and ex-McKinsey consultants, with research output published in peer-reviewed outlets including NEJM, The Lancet Digital Health, JMIR, PLOS, and ASCO. In 2025 the firm opened its first international office in the US (led by Ryan Callahan) and expanded its capability-building practice via the appointment of Dr Des Conroy.

Prova Health Limited is privately held and founder-owned, with no disclosed external venture capital or institutional funding rounds; co-founders Gianluca Fontana (CEO) and Dr Saira Ghafur (CMO) remain in operating roles alongside a board advisor cohort that includes a former pharma chief medical officer (Dr Samin Saeed). The firm is small (11-50 employees), differentiated primarily through its clinical simulation methodology for AI evaluation rather than through scale or product breadth.

Name

Prova Health

Legal name

Prova Health Limited

Website

https://provahealth.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Prova Health is a London-headquartered health innovation consultancy that provides clinical evidence generation, economic evidence, and market access services to pharmaceutical companies, digital health and AI innovators, and health systems, supported by a network of 100,000+ clinicians across 50+ countries.

Ownership category

akta.pro rank

Product category

Healthcare Innovation Consulting

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

akta.pro secondary industry

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

• Health evidence generation
• Clinical simulation methodology
• Digital health consultancy
• Market access services
• Health economics research

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Evidence Generation Services: Professional consulting services for clinical evidence generation, economic evidence development, and market access strategy for digital health and pharma companies.
2. Capability Building Programs: Customized training and education programs for healthcare and life sciences organizations, including online learning modules, workshops, and executive programs delivered to pharma and diagnostics companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Prova Health is a professional services firm that delivers evidence generation, market access, and capability building services for pharma companies, digital health and AI innovators, and health systems. Its service portfolio spans clinical evidence generation (including clinical simulation, pragmatic trials, and real-world evidence), health economics and outcomes research demonstrating cost-effectiveness to payors, and commercialisation support covering DiGA reimbursement in Germany and US healthcare reimbursement navigation. These are delivered alongside the Learn by Prova Health online learning platform and the firm's global clinician network used for validation activities.

Product overview

Prova Health is a health innovation consultancy offering a unified portfolio of evidence generation, market access, and capability building services for digital health and AI innovators. The core service offering comprises three integrated practice areas: Clinical Evidence Services (including clinical simulation methodology), Economic Evidence Services (health economics and outcomes research), and Market Access Services (including DiGA reimbursement support in Germany and US healthcare navigation). Supporting these core practices is the Prova Health Network (a platform connecting 100,000+ clinicians for validation activities), Capability Building programmes delivered via the Learn by Prova Health online platform, and specialist AI workforce evaluation tools. The company focuses on helping health innovators achieve regulatory approval, secure reimbursement, and drive clinical adoption at scale.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Evidence Services End-to-end clinical evidence generation services for digital health and AI innovators and pharmaceutical companies, including study design, clinical simulation, pragmatic clinical trials, and real-world evidence generation to demonstrate safety and effectiveness for regulatory approval and adoption.
• Economic Evidence Services Health economics and outcomes research services including cost-effectiveness analysis, economic modelling, and value demonstration for payors and health systems to support commercial decision-making on digital health and pharma solutions.
• Market Access Services Commercialisation support for digital health solutions including DiGA reimbursement in Germany, US healthcare reimbursement navigation, and market entry strategy across priority markets.
• Prova Health Network A global network of more than 100,000 clinicians and healthcare professionals (doctors, academics, executives, payors, regulators, policymakers) across 25+ therapeutic areas and 50+ countries, recruited to support clinical validation activities and clinician-facing trials for Prova Health's clients.
• Capability Building Organisational training and education programmes for pharmaceutical and life sciences organisations, including healthcare systems academies, therapeutic area training (e.g., cancer care), and commercial capability development delivered for pharma and digital health companies.
• Learn by Prova Health Online learning platform offering educational programmes for healthcare and life sciences professionals, including eLearning modules, masterclasses, and in-person workshops deployed via client LMS systems.
• Clinical Simulation Evaluation Prova Health's proprietary evidence generation methodology using synthetic patient data and clinical vignettes in realistic scenarios to evaluate digital health and AI technologies rapidly and cost-effectively before real-world deployment. Used particularly for LLM-based and generative AI clinical tools, enabling evidence generation in weeks or months rather than years.

Quantifiable outcome

• 415 seconds vs 527 seconds for tumor board summary preparation with LLM tool
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• getUBettercoreStrategic or Co-development PartnerProva Health is designing and delivering an independent evaluation of the getUBetter women's pelvic health service at Cwm Taf Morgannwg University Health Board as part of a successful SBRI Wales grant. This partnership involves mixed-methods system evaluation to validate a localized digital pathway for women's pelvic health.
• Outbound AIcoreStrategic or Co-development PartnerOutbound AI supported Prova Health's white paper on 'The financial case for an AI workforce in providers' revenue cycle operations'. The partnership produced a quantitative framework and companion interactive model for healthcare leaders to assess financial impacts of AI workforce solutions in RCM operations.
• BluePath HealthcoreStrategic or Co-development PartnerCollaborated to host an intimate dinner salon in New York bringing together cross-sector health leaders to discuss healthcare adoption challenges. The partnership focused on decision-ready evidence and tools like clinical simulation and data sandboxes for faster learning and earlier risk reduction.
• Roche (navify Clinical Hub)coreStrategic or Co-development PartnerConducted independent clinical simulation evaluation of Roche's navify Clinical Hub (nCH) for Oncology, testing LLM-based summarization tool across four major markets (US, UK, Spain, Singapore). Study accepted at ASCO Annual Meeting, demonstrating credibility of methodology.
• Una HealthminorStrategic or Co-development PartnerDr Matthew Fenech, Co-Founder & CMedO at Una Health, provided expert contributions to the DiGA reimbursement guide article, offering insights on German market access for digital health solutions.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Largest global CRO and life sciences data/analytics provider; offers overlapping evidence generation, real-world evidence, and market access services as part of broader portfolio.
• Parexel International: Large CRO offering clinical evidence, HEOR, and market access services to pharma; broader portfolio but overlaps with Prova's clinical evidence practice.
• Charles River Associates (CRA): Life sciences practice of management consultancy providing economic evidence, market access, and strategic consulting to pharma; comparable consulting-led model.
• ICON plc: Global CRO with established evidence, market access, and digital health practices; competes for enterprise pharma evidence contracts at greater scale.

Direct peers

• MDisrupt: Healthtech-focused evidence and expert network platform connecting digital health companies with clinicians for validation and market insights; strong functional overlap with Prova Health Network.
• Trinity Life Sciences: Life sciences strategy and evidence generation firm supporting pharma with commercial evidence, market access, and digital health strategy; comparable services and client base.
• Open Health: Global evidence, market access, and HEOR consultancy with deep roots in UK/EU markets — directly comparable service portfolio to Prova.
• Evidera (Advarra): Health economics, outcomes research, and market access consultancy serving pharma and digital health companies; comparably positioned in HEOR and evidence generation.
• Lumanity: Global consultancy providing evidence generation, market access, and HEOR services to pharma and digital health innovators — closest direct peer to Prova across service lines.

Emerging players

• BluePath Health: Health innovation advisory firm focused on adoption acceleration, evidence translation, and cross-sector convening — co-hosted Prova's NY dinner salon and operates in adjacent digital health evidence space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/provahealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prova Health